Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors

FASEB Journal

Volumn 20, Issue 11, 2006, Pages

  Movafagh, Sharareh ^a   Hobson, John P ^c   Spiegel, Sarah ^b   Kleinman, Hynda K ^c   Zukowska, Zofia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Bimodal dose response curve; Chemotaxis; GPCRs; Mitogenesis; Oligomerization

Indexed keywords

MATRIGEL; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; CAPILLARY; CELL CULTURE; CELL DIVISION; CELL LINE; CELL MOTION; CYTOLOGY; DRUG EFFECT; MICROCIRCULATION; PHYSIOLOGY; SKIN; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

CAPILLARIES; CELL DIVISION; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SKIN; UMBILICAL VEINS;

EID: 33845583352     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4770fje     Document Type: Article

References (55)

1. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674
2. Campochiaro, P. A., and Hackett, S. F. (2003) Ocular neovascularization: a valuable model system. Oncogene 22, 6537-6548
3. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat. Med. 9, 653-660
4. Folkman, J. (1974) Tumor angiogensis: role in regulation of tumor growth. Symp. Soc. Dev. Biol. 30, 43-52
5. Patz, A. (1978) Current concepts in ophthalmology. Retinal vascular diseases. N. Engl. J. Med. 298, 1451-1454
6. Conway, E. M., Collen, D., and Carmeliet, P. (2001) Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507-521
7. Ferrara, N. (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin. Oncol. 29, 10-14
8. Schweigerer, L. (1989) Fibroblast growth factor and angiogenesis. Z. Kardiol. 78 Suppl. 6, 12-15
9. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395
10. Lee, E. W., Grant, D. S., Movafagh, S., and Zukowska, Z. (2003) Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 24, 99-106
11. Lee, E. W., Michalkiewicz, M., Kitlinska, J., Kalezic, I., Switalska, H., Yoo, P., Sangkharat, A., Ji, H., Li, L., Michalkiewicz, T., et al. (2003) Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J. Clin. Invest. 111, 1853-1862
12. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., Yeh, Y., Chen, W. T., Kleinman, H. K., Grouzmann, E., et al. (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83, 187-195
13. Allen, J. M., Adrian, T. E., Polak, J. M., and Bloom, S. R. (1983) Neuropeptide Y (NPY) in the adrenal gland. J. Auton. Nerv. Syst. 9, 559-563
14. Lundberg, J. M., Terenius, L., Hokfelt, T., Martling, C. R., Tatemoto, K., Mutt, V., Polak, J., Bloom, S., and Goldstein, M. (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-480
15. Berglund, M. M., Hipskind, P. A., and Gehlert, D. R. (2003) Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. (Maywood) 228, 217-244
16. Phillips, J. K., McLean, A. J., and Hill, C. E. (1998) Receptors involved in nerve-mediated vasoconstriction in small arteries of the rat hepatic mesentery. Br. J. Pharmacol. 124, 1403-1412
17. Pons, J., Kitlinska, J., Ji, H., Lee, E. W., and Zukowska, Z. (2003) Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can. J. Physiol. Pharmacol. 81, 177-185
18. Zukowska, Z., Grant, D. S., and Lee, E. W. (2003) Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc. Med. 13, 86-92
19. Kitlinska, J., Lee, E. W., Movafagh, S., Pons, J., and Zukowska, Z. (2002) Neuropeptide Y-induced angiogenesis in aging. Peptides 23, 71-77
20. Ghersi, G., Chen, W., Lee, E. W., and Zukowska, Z. (2001) Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22, 453-458
21. Koulu, M., Movafagh, S., Tuohimaa, J., Jaakkola, U., Kallio, J., Pesonen, U., Geng, Y., Karvonen, M. K., Vainio-Jylha, E., Pollonen, M., et al. (2004) Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann. Med. 36, 232-240
22. Bouali, S. M., Fournier, A., St-Pierre, S., and Jolicoeur, F. B. (1995) Effects of NPY and NPY2-36 on body temperature and food intake following administration into hypothalamic nuclei. Brain Res. Bull. 36, 131-135
23. Duhault, J., Boulanger, M., Chamorro, S., Boutin, J. A., Della Zuana, O., Douillet, E., Fauchere, J. L., Feletou, M., Germain, M., Husson, B., et al. (2000) Food intake regulation in rodents: Y5 or Y1 NPY receptors or both? Can. J. Physiol. Pharmacol. 78, 173-185
24. Jinde, S., Masui, A., Morinobu, S., Noda, A., and Kato, N. (2002) Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat. Neuroscience 115, 1035-1045
25. Herzog, H., Darby, K., Ball, H., Hort, Y., Beck-Sickinger, A., and Shine, J. (1997) Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation. Genomics 41, 315-319
26. Li, L., Lee, E. W., Ji, H., and Zukowska, Z. (2003) Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 23, 1204-1210
27. Bouis, D., Hospers, G. A., Meijer, C., Molema, G., and Mulder, N. H. (2001) Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4, 91-102
28. Grant, D. S., Kinsella, J. L., Fridman, R., Auerbach, R., Piasecki, B. A., Yamada, Y., Zain, M., and Kleinman, H. K. (1992) Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J. Cell. Physiol. 153, 614-625
29. Anderson, R. L., Morris, J. L., and Gibbins, I. L. (2001) Neurochemical differentiation of functionally distinct populations of autonomic neurons. J. Comp. Neurol. 429, 419-435
30. Zukowska-Grojec, Z., Konarska, M., and McCarty, R. (1988) Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci. 42, 1615-1624
31. Smialowska, M., and Bajkowska, M. (1997) Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical studies. Pol. J. Pharmacol. 49, 357-362
32. Husum, H., Gruber, S. H., Bolwig, T. G., and Mathe, A. A. (2002) Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade. Neuropeptides 36, 363-369
33. Rosen, L. S. (2002) Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control. 9, 36-44
34. Klagsbrun, M. (1992) Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin. Cancer Biol. 3, 81-87
35. Jih, Y., Lien, W., Tsai, W., Yang, G., Li, C., and Wu, L. (2002) Distinct regulation of genes by bFGF and VEGF-A in endothelial cells. Angiogenesis 4, 313-321
36. Cavadas, C., Silva, A. P., Mosimann, F., Cotrim, M. D., Ribeiro, C. A., Brunner, H. R., and Grouzmann, E. (2001) NPY regulates catecholamine secretion from human adrenal chromaffin cells. J. Clin. Endocrinol. Metab. 86, 5956-5963
37. Grundemar, L., Wahlestedt, C., and Reis, D. J. (1991) Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J. Pharmacol. Exp. Ther. 258, 633-638
38. Balasubramaniam, A., Sheriff, S., Rigel, D. F., and Fischer, J. E. (1990) Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides 11, 545-550
39. Nan, Y. S., Feng, G. G., Hotta, Y., Nishiwaki, K., Shimada, Y., Ishikawa, A., Kurimoto, N., Shigei, T., and Ishikawa, N. (2003) Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer. Am. J. Physiol. 286, H1027-H1033. Epub 2003 Oct 23
40. Kitlinska, J., Abe, K., Kuo, L., Pons, J., Yu, M., Li, L., Tilan, J., Everhart, L., Lee, E. W., Zukowska, Z., et al. (2005) Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res. 65, 1719-1728
41. Zukowska-Grojec, Z., Pruszczyk, P., Colton, C., Yao, J., Shen, G. H., Myers, A. K., and Wahlestedt, C. (1993) Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14, 263-268
42. Kim, J., Ruff, M., Karwatowska-Prokopczuk, E., Hunt, L., Ji, H., Pert, C. B., and Zukowska-Grojec, Z. (1998) HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. Regul. Pept. 75-76, 201-205
43. Vezzani, A., Moneta, D., Mule, F., Ravizza, T., Gobbi, M., and French-Mullen, J. (2000) Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures. Epilepsia 41 Suppl. 6, S115-S121
44. Desai, K. S., Li, K. C., and Angel, A. (1973) Bimodal effect of insulin on hormone-stimulated lipolysis: relation to intracellular 3′,5′- cyclic adenylic acid and free fatty acid levels. J. Lipid Res. 14, 647-655
45. Oh-Ishi, T. (1981) [The in vitro proliferative response of human peripheral blood lymphocytes stimulated with purified concanavalin A and the analysis of subpopulations of T-cells (author's transl.)]. Hokkaido Igaku Zasshi. 56, 421-430
46. Gerozissis, K., Saadi, M., and Dray, F. (1987) Leukotrienes C4 and D4 stimulate the release of luteinizing hormone-releasing hormone from rat median eminence in vitro. Brain Res. 416, 54-58
47. Grigor'ev, E. I., Khavinson, V., Malinin, V. V., Grigor'ev, A. E., Kochnev, I. N., and Kudriavtseva, T. A. (2003) [The study of the role of the water medium in the mechanism of action of peptides in low and ultra low doses]. Radiats. Biol. Radioecol. 43, 358-362
48. Nakamura, J., Purvis, E. R., and Swenberg, J. A. (2003) Micromolar concentrations of hydrogen peroxide induce oxidative DNA lesions more efficiently than millimolar concentrations in mammalian cells. Nucleic Acids Res. 31, 1790-1795
49. Gupta, S. K., Pillarisetti, K., Thomas, R. A., and Aiyar, N. (2001) Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists. Immunol. Lett. 78, 29-34
50. Price, M. L., and Lucki, I. (2001) Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J. Neurosci. 21, 2833-2841
51. Palmer, J. M., and Wallis, M. (1989) Human growth hormone stimulates somatomedin C/insulin-like growth factor I production by the human lymphoid cell line, IM-9. Mol. Cell. Endocrinol. 63, 167-173
52. Morl, K., Bohme, I., Dinger, M., Rennert, R., and Beck-Sickinger, A. G.(2004) Analysis of NPY receptor dimerization in living cells by fluorescence resonance energy transfer (FRET). In 7th International NPY Meeting, p. S1.3, Coimbra
53. Schober, D. S., Berglund, M. M., and Gehlert, D. R. (2004) Co-expression of neuropeptide Y Y1 and Y5 receptor forms a constitutive heterodimer with distinct functional properties. In 7th International NPY Meeting, p. P1.6., Coimbra52.
54. Agnati, L. F., Ferre, S., Lluis, C., Franco, R., and Fuxe, K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550
55. Mannon, P. J., and Raymond, J. R. (1998) The neuropeptide Y/peptide YY Y1 receptor is coupled to MAP kinase via PKC and Ras in CHO cells. Biochem. Biophys. Res. Commun. 246, 91-94